Genvivo Services

Genvivo specializes in pre-clinical assessments and evaluation of novel compounds or protein based biologics as therapeutic agents for the treatment of diabetes, inflammation, cancer, neurological and metabolic diseases. The company's senior leadership has over 30 years of drug discovery experience in small molecules and  recombinant protein biologics utilizing conventional, gene knock-out, orthotopic, xenograft and transgenic animal models.  Genvivo offers over 100 animal models along with complimentary services such as cell based preclinical efficacy testing, pharmacokinetics studies, pharmacodynamics, and pre-GLP toxicology testing in vitro and in vivo.